News Breaks |
|
|
| November 27, 2012 |
| 16:16 EDT |  | ECTE | Echo Therapeutics intends to offer common stock, no amount given
Aegis Capital Corp. is acting as the sole book-running manager for the offering. |
|
|
News For ECTE From The Last 14 Days Check below for free stories on ECTE the last two weeks. |
|
|
| June 14, 2013 |
| 09:28 EDT | | ECTE | Echo Therapeutics 4.025M share Secondary priced at $2.70
 Subscribe for More Information |
|
| June 13, 2013 |
| 19:40 EDT | | ECTE | Echo Therapeutics 4.025M share Secondary priced at $2.70
Aegis acted as sole book running manager for the offering. |
|
| June 10, 2013 |
| 07:52 EDT |  | ECTE | Echo Therapeutics submits pre-submission package to FDA for Symphony CGM system
Echo Therapeutics announced that it has submitted a pre-submission package to the FDA for the Symphony CGM System for use in the hospital critical care environment. In conjunction with the pre-submission package, the company has requested a meeting with the FDA to work cooperatively on the clinical and regulatory plan to support FDA approval of the System. The pre-submission documentation has been submitted to the FDA in order to obtain the Agency's guidance regarding the U.S. regulatory pathway for Symphony, the proper approach to refining the pivotal trial protocol and endpoints, and preparing the pre-marketing application. |
|
| June 6, 2013 |
| 16:35 EDT | | ECTE | Echo Therapeutics announce 1-for-10 reverse stock split
Subscribe for More Information |
|
| June 5, 2013 |
| 07:51 EDT | | ECTE | Echo Therapeutics initiates clinical trial of Symphony CGM system
Subscribe for More Information |
|
|
|
|
|
